84 HR Lyllana 0.00313 MG/HR Transdermal System

RxCUI: 2399901
RxNorm name: 84 HR Lyllana 0.00313 MG/HR Transdermal System
Display name: 84 HR Lyllana 0.00313 MG/HR Transdermal System
Full name: 84 HR Lyllana 0.00313 MG/HR Transdermal System
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
LYLLANA	ESTRADIOL	Amneal Pharmaceuticals LLC	09c472c6-a38a-4a3d-b048-6fefd52e2ad3	2024-05-15	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2399901

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
09c472c6-a38a-4a3d-b048-6fefd52e2ad3	84 HR Lyllana 0.00313 MG/HR Transdermal System	SY	15	These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 1975	20240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad3	Lyllana 0.075 MG/Day Twice Weekly Transdermal Patch	SY	15	These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 1975	20240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad3	Lyllana 0.075 MG/Day Twice Weekly Transdermal System	PSN	15	These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 1975	20240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad3	84 HR estradiol 0.00313 MG/HR Transdermal System [Lyllana]	SBD	15	These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 1975	20240515